US 12,213,730 B2
Device and method for in vivo detection of clots within circulatory vessels
Vladimir Pavlovich Zharov, Little Rock, AR (US); and Ekaterina Galanzha, Little Rock, AR (US)
Assigned to BioVentures, LLC, Little Rock, AR (US)
Filed by BioVentures, LLC, Little Rock, AR (US)
Filed on Feb. 3, 2023, as Appl. No. 18/105,636.
Application 15/240,712 is a division of application No. 13/253,767, filed on Oct. 5, 2011, granted, now 9,451,884, issued on Sep. 27, 2016.
Application 18/105,636 is a continuation of application No. 17/496,995, filed on Oct. 8, 2021, granted, now 11,571,255.
Application 17/496,995 is a continuation of application No. 15/240,712, filed on Aug. 18, 2016, granted, now 11,154,360, issued on Oct. 26, 2021.
Application 13/253,767 is a continuation in part of application No. 12/945,576, filed on Nov. 12, 2010, granted, now 9,144,383, issued on Sep. 29, 2015.
Application 12/945,576 is a continuation in part of application No. 12/334,217, filed on Dec. 12, 2008, abandoned.
Claims priority of provisional application 61/013,543, filed on Dec. 13, 2007.
Prior Publication US 2023/0270497 A1, Aug. 31, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 5/00 (2006.01); A61B 5/02 (2006.01); A61B 5/145 (2006.01); A61B 5/1495 (2006.01); A61B 8/06 (2006.01); A61B 8/08 (2006.01); A61B 18/24 (2006.01); A61K 49/22 (2006.01); B03C 1/28 (2006.01); B03C 1/30 (2006.01); G01N 21/17 (2006.01); G01N 29/24 (2006.01); G01N 29/44 (2006.01); A61B 18/00 (2006.01); A61B 18/18 (2006.01); A61B 18/20 (2006.01); G01N 15/14 (2006.01); G01N 15/1434 (2024.01)
CPC A61B 18/245 (2013.01) [A61B 5/0059 (2013.01); A61B 5/0095 (2013.01); A61B 5/02007 (2013.01); A61B 5/14535 (2013.01); A61B 5/1495 (2013.01); A61B 5/412 (2013.01); A61B 5/415 (2013.01); A61B 5/416 (2013.01); A61B 5/418 (2013.01); A61B 5/4839 (2013.01); A61B 5/7282 (2013.01); A61B 5/7405 (2013.01); A61B 5/742 (2013.01); A61B 5/7455 (2013.01); A61B 5/746 (2013.01); A61B 8/06 (2013.01); A61B 8/481 (2013.01); A61K 49/22 (2013.01); B03C 1/288 (2013.01); B03C 1/30 (2013.01); G01N 21/1702 (2013.01); G01N 29/2418 (2013.01); G01N 29/4427 (2013.01); A61B 8/08 (2013.01); A61B 2018/0041 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/0088 (2013.01); A61B 18/1815 (2013.01); A61B 18/20 (2013.01); B03C 2201/06 (2013.01); B03C 2201/26 (2013.01); G01N 15/1425 (2013.01); G01N 15/1434 (2013.01); G01N 15/147 (2013.01); G01N 2015/1477 (2013.01); G01N 2201/0221 (2013.01)] 18 Claims
OG exemplary drawing
 
1. A method for continuous monitoring of a circulatory vessel of a living organism, the method comprising:
pulsing circulating target objects comprising red blood cells and at least one clot within the circulatory vessel with at least one pulse of laser energy at a first pulse wavelength ranging between 400 nm and 2500 nm, wherein the first pulse wavelength induces a photoacoustic signal from the circulating target objects, wherein the at least one clot is a hemoglobin-rich red clot, a platelet-rich white clot, or a combination thereof and wherein the hemoglobin-rich clot is light absorbing and the platelet-rich white clot is non-absorbing;
obtaining a photoacoustic pattern induced by the at least one pulse of laser energy, wherein the photoacoustic pattern comprises at least one photoacoustic signal comprising a blood background signal produced by the red blood cells;
simultaneously obtaining fluorescence, scattering, and photothermal signals from the target objects, via a photodetector;
processing photoacoustic, fluorescence, scattering, and photothermal signals;
analyzing a combination of the photoacoustic pattern and the fluorescence, scattering, and/or photothermal signals to determine the presence of the at least one clot, wherein analyzing the photoacoustic pattern comprises determining the presence of positive and negative contrast peaks in the photoacoustic pattern indicating the presence of a red clot, a white clot, or a combination thereof, wherein the negative contrast in the photoacoustic pattern below the blood background signal indicates the presence of the white clot, the positive contrast in the photoacoustic pattern above the blood background signal indicates the presence of the red clot, and a combination of positive contrast and negative contrast indicates the presence of a combination of red and white clots; and
producing a detection signal when the photoacoustic pattern and the fluorescence signal, scattering signal, photothermal signal, or combinations thereof indicates the presence of a clot.